Publications

5808 Results

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group.

Authors
DR Gandara;J Crowley;RB Livingston;EA Perez;CW Taylor;G Weiss;JR Neefe;LF Hutchins;RW Roach;SM Grunberg;TJ Braun;RB Natale;SP Balcerzak
Journal / Conference
Classic Papers and Current Comments 2(1):178-184
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8738

Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience.

Authors
KS Albain;JJ Crowley;M LeBlanc;RB Livingston
Journal / Conference
Classic Papers and Current Comments 2(1):135-144
Year
1997
Research Committee(s)
Lung

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805.

Authors
KS Albain;VW Rusch;JJ Crowley;TW Rice;AT Turrisi III;JK Weick;VA Lonchyna;CA Presant;RJ McKenna;DR Gandara;H Fosmire;SA Taylor;KJ Stelzer;KR Beasley;RB Livingston
Journal / Conference
Classic Papers and Current Comments 2(1):145-158
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8805

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: A Southwest Oncology Group study.

Authors
JK Weick;J Crowley;RB Natale;BL Hom;S Rivkin;CA Coltman Jr;SA Taylor;RB Livingston
Journal / Conference
Classic Papers and Current Comments (2)1:172-177
Year
1997
Research Committee(s)
Lung
Study Number(s)
SWOG-8241

Meeting report: Bone and soft tissue sarcomas: Summary of the third United States/Japan clinical trials summit

Authors
A Uchida;M Fukushima;ML Rothenberg;CA Coltman Jr
Journal / Conference
Journal of Cancer Research and Clinical Oncology 123:674-677
Year
1997
Research Committee(s)
Sarcoma

Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma.

Authors
LE Flaherty;PY Liu;JM Unger;VK Sondak
Journal / Conference
American Journal of Clinical Oncology 20(6):600-604
Year
1997
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921

Chemoprevention of prostate cancer: The prostate cancer prevention trial.

Authors
IM Thompson;CA Coltman Jr;J Crowley
Journal / Conference
The Prostate 33:217-221
Year
1997
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Utility of the enrollment period in the prostate cancer prevention trial (PCPT).

Authors
PJ Goodman;L Lovato;A Ryan;J Crowley;C Moinpour;I Thompson
Journal / Conference
Controlled Clinical Trials 18(S3)(#19):52S
Year
1997
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Data operations management with clinical datafax: The prostate cancer prevention trial (PCPT) experience.

Authors
AM Ryan;L Emel;P Goodman
Journal / Conference
Controlled Clinical Trials 18(S3)(#P74):156S
Year
1997
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Phase II intergroup trial of fludarabine (FAMP) in Waldenstrom's macroglobulinemia (WM): Results of Southwest Oncology Group trial (SWOG 9003).

Authors
M Dhodapkar;J Jacobson;M Gertz;J Crowley;M Shurafa;S Salmon;R Kyle;B Barlogie
Journal / Conference
Blood 90(10)Suppl.1:577a(#2571)
Year
1997
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9003